Gürdal C, Erdener U, Orhan M, Irkeç M
Ophthalmology Department, PTT Education and Research Hospital, Ankara, Turkey.
Eur J Ophthalmol. 2003 Mar;13(2):202-6. doi: 10.1177/112067210301300213.
Either autogenous or allograft fascia lata frontal sling procedures can be used for the treatment of severe ptosis. We retrospectively evaluated the late outcomes of both approaches.
Medical records of patients who underwent frontal sling ptosis surgery between 1978 and 2000, with a follow-up of one year or more were included in the study. Success rates and the complications of the surgery for autogenous and allograft fascia lata were recorded. The results were compared statistically.
Surgeries were performed with 82 autogenous or 43 allograft fascia lata. At last follow-up there were 71 eyes (86.6%) with good, 8 eyes (9.7%) with moderate, 3 eyes (3.7%) with poor results after autogenous fascia lata and 35 (81.4%), 3 (7%) and 5 (11.6%) after the allograft fascia lata frontal sling procedure. There was no significant difference between the two groups. Repeat surgery was carried out on three patients after autogenous and five after allograft fascia lata surgery. Two cases of preseptal cellulitis were observed, one abscess after autogenous and one lagophthalmus after allograft fascia lata sling surgery. All patients had slight edema early after surgery which resolved in a few days. Only one patient developed a hematoma at the site of the leg incision.
Although the long-term success rate with the autogenous fascia lata is slightly higher and this remains the first choice, allograft fascia lata is a good alternative in patients in whom fascia could not be harvested.
自体阔筋膜或同种异体阔筋膜额肌悬吊术均可用于治疗重度上睑下垂。我们回顾性评估了这两种方法的远期疗效。
纳入1978年至2000年间接受额肌悬吊上睑下垂手术且随访1年或更长时间的患者的病历。记录自体阔筋膜和同种异体阔筋膜手术的成功率及并发症。对结果进行统计学比较。
分别用82例自体阔筋膜或43例同种异体阔筋膜进行手术。末次随访时,自体阔筋膜手术后71只眼(86.6%)效果良好,8只眼(9.7%)效果中等,3只眼(3.7%)效果差;同种异体阔筋膜额肌悬吊术后分别为35只眼(81.4%)、3只眼(7%)和5只眼(11.6%)。两组之间无显著差异。自体阔筋膜手术后3例患者、同种异体阔筋膜手术后5例患者进行了再次手术。观察到2例眶隔前蜂窝织炎,自体阔筋膜手术后1例脓肿形成,同种异体阔筋膜悬吊术后1例出现兔眼。所有患者术后早期均有轻微水肿,数天内消退。仅1例患者在腿部切口处出现血肿。
虽然自体阔筋膜的长期成功率略高,仍是首选,但对于无法获取阔筋膜的患者,同种异体阔筋膜是一种很好的替代选择。